Skip to main content
Caplight Logo









LPOXY Therapeutics

LPOXY Therapeutics

Private
Platte City, MissouriHealthcare & Life Scienceshttps://www.lpoxy.com/

Last Round

Series A

Sep 3, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

LPOXY Therapeutics is a biopharmaceutical company developing SIDIPREV™, an orally-administered, metered-dose intestinal oxygen delivery therapeutic designed to prevent Clostridioides difficile colitis infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalinfectious diseaseC. difficileclinical-stagedrug developmentnon-antibiotic therapyintestinal oxygen deliverygut microbiomeLPADLimited Population Pathwaybiotech startupdrug discoveryclinical trialsmicrobiome therapeuticshospital-acquired infection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LPOXY Therapeutics Comparables

Compare LPOXY Therapeutics with similar companies based on industry and business-model similarity.

LPOXY Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Theriva Biologics
76%
Lumen Bioscience
76%
Crestone, Inc.
75%

LPOXY Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 3, 2025

LPOXY Therapeutics Investors

Notable investors and investment history

LPOXY Therapeutics investors
InvestorRounds
5 Horizons VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors grew 129% MoM.

  • Sep 4, 2025

    Developing non-antibiotic therapy for C. difficile infections.

LPOXY Therapeutics Filings

Explore SEC and related filing metadata, where available.

LPOXY Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LPOXY Therapeutics's valuation, stock price, and market status.

Is LPOXY Therapeutics a public or private company?

LPOXY Therapeutics is a private company.

What is the current stock price of LPOXY Therapeutics?

LPOXY Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is LPOXY Therapeutics worth (valuation)?

Valuation information for LPOXY Therapeutics is not publicly available.

Can I buy LPOXY Therapeutics stock?

LPOXY Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LPOXY Therapeutics's last funding round?

LPOXY Therapeutics's most recent funding round was Series A on September 3, 2025.

Who are the main investors in LPOXY Therapeutics?

Key investors in LPOXY Therapeutics include 5 Horizons Ventures.

Will LPOXY Therapeutics IPO soon?

No public IPO plans have been announced for LPOXY Therapeutics.

How can I track LPOXY Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LPOXY Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPlatte City, Missouri
Employee Range1
Year Founded2020
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?